Discover more about Catamaran Bio.

Catamaran bio cambridge. Catamaran Bio unveiled Monday has been quietly incubating at LabCentral in Cambridge since July and has 42 million raised by five venture capital firms. Catamaran Bio has an office in Cambridge. This funding round was led by Lightstone Ventures and Sofinnova Partners and included participation from the founding investor of Catamaran Bio SV health investors.

It was founded in 2020 and headquartered in Cambridge Massachusetts. CATAMARAN and TAILWIND are trademarks of Catamaran Bio Inc. All other trademarks referenced herein are the property.

CAMBRIDGE MassCatamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need announced the appointment of Alvin Shih MD MBA as President and Chief Executive Officer. This round is a part of their launch financing. Alvin Shih as President and Chief Executive Officer.

CAMBRIDGE Mass-- BUSINESS WIRE--Catamaran Bio announces appointment of Dr. April 26 2021 Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat patients with significant unmet medical need today announced the appointment of Scott Holmes MS MBA as Chief Financial OfficerMr. Catamaran Bio is developing novel off-the-shelf CAR-NK cell therapies designed to treat a broad range of cancers including solid tumors.

November 23 2020 Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer today announced that the company has launched with 42 million in financing. Based biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer launched with. Our current products cover broad spectrum of biological areas such as Virology Immunology.

April 26 2021 Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat patients with significant unmet medical need today announced the appointment of Scott Holmes MS MBA as Chief Financial OfficerMr. It offers cell therapy company developing allogeneic off-the-shelf products for patients with an unmet medical need. It offers cell therapy company developing allogeneic off-the-shelf products for patients with an unmet medical needIt was founded in 2020 and headquartered in Cambridge Massachusetts.